BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16246156)

  • 1. The regulation of cell migration by PTEN.
    Leslie NR; Yang X; Downes CP; Weijer CJ
    Biochem Soc Trans; 2005 Dec; 33(Pt 6):1507-8. PubMed ID: 16246156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The INPP4B paradox: Like PTEN, but different.
    Hamila SA; Ooms LM; Rodgers SJ; Mitchell CA
    Adv Biol Regul; 2021 Dec; 82():100817. PubMed ID: 34216856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate specificity and acute regulation of the tumour suppressor phosphatase, PTEN.
    Downes CP; Perera N; Ross S; Leslie NR
    Biochem Soc Symp; 2007; (74):69-80. PubMed ID: 17233581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the PTEN phosphatase.
    Gericke A; Munson M; Ross AH
    Gene; 2006 Jun; 374():1-9. PubMed ID: 16675164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
    Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM
    Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration.
    Dey N; Crosswell HE; De P; Parsons R; Peng Q; Su JD; Durden DL
    Cancer Res; 2008 Mar; 68(6):1862-71. PubMed ID: 18339867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PtdIns(3,4,5)P(3)-dependent and -independent roles for PTEN in the control of cell migration.
    Leslie NR; Yang X; Downes CP; Weijer CJ
    Curr Biol; 2007 Jan; 17(2):115-25. PubMed ID: 17240336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttranslational Regulation and Conformational Plasticity of PTEN.
    Kotelevets L; Trifault B; Chastre E; Scott MGH
    Cold Spring Harb Perspect Med; 2020 Jul; 10(7):. PubMed ID: 31932468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell activation-induced phosphoinositide 3-kinase alpha/beta dimerization regulates PTEN activity.
    Pérez-García V; Redondo-Muñoz J; Kumar A; Carrera AC
    Mol Cell Biol; 2014 Sep; 34(18):3359-73. PubMed ID: 24958106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic switching of PI3K-dependent lipid signals.
    Downes CP; Leslie NR; Batty IH; van der Kaay J
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):188-92. PubMed ID: 17371235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of agonist-sensitive PtdIns(3,4,5)P3 reveals a nuclear pool that is insensitive to PTEN expression.
    Lindsay Y; McCoull D; Davidson L; Leslie NR; Fairservice A; Gray A; Lucocq J; Downes CP
    J Cell Sci; 2006 Dec; 119(Pt 24):5160-8. PubMed ID: 17158918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN and Other PtdIns(3,4,5)P
    Csolle MP; Ooms LM; Papa A; Mitchell CA
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.
    Maehama T; Dixon JE
    J Biol Chem; 1998 May; 273(22):13375-8. PubMed ID: 9593664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulation of cell motility and chemotaxis by phospholipid signaling.
    Kölsch V; Charest PG; Firtel RA
    J Cell Sci; 2008 Mar; 121(Pt 5):551-9. PubMed ID: 18287584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation and modulation of PTEN activity.
    Naderali E; Khaki AA; Rad JS; Ali-Hemmati A; Rahmati M; Charoudeh HN
    Mol Biol Rep; 2018 Dec; 45(6):2869-2881. PubMed ID: 30145641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Axonal Membrane Protein PRG2 Inhibits PTEN and Directs Growth to Branches.
    Brosig A; Fuchs J; Ipek F; Kroon C; Schrötter S; Vadhvani M; Polyzou A; Ledderose J; van Diepen M; Holzhütter HG; Trimbuch T; Gimber N; Schmoranzer J; Lieberam I; Rosenmund C; Spahn C; Scheerer P; Szczepek M; Leondaritis G; Eickholt BJ
    Cell Rep; 2019 Nov; 29(7):2028-2040.e8. PubMed ID: 31722215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of PI 3-kinase-dependent signalling pathways by the tumour suppressor protein, PTEN.
    Downes CP; Bennett D; McConnachie G; Leslie NR; Pass I; MacPhee C; Patel L; Gray A
    Biochem Soc Trans; 2001 Nov; 29(Pt 6):846-51. PubMed ID: 11709086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-organization of the phosphatidylinositol lipids signaling system for random cell migration.
    Arai Y; Shibata T; Matsuoka S; Sato MJ; Yanagida T; Ueda M
    Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12399-404. PubMed ID: 20562345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN modulates GDNF/RET mediated chemotaxis and branching morphogenesis in the developing kidney.
    Kim D; Dressler GR
    Dev Biol; 2007 Jul; 307(2):290-9. PubMed ID: 17540362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitination of PTEN (phosphatase and tensin homolog) inhibits phosphatase activity and is enhanced by membrane targeting and hyperosmotic stress.
    Maccario H; Perera NM; Gray A; Downes CP; Leslie NR
    J Biol Chem; 2010 Apr; 285(17):12620-8. PubMed ID: 20177066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.